1989
DOI: 10.1016/s0378-4347(00)83014-5
|View full text |Cite
|
Sign up to set email alerts
|

Determination of enantiomeric purity of the new D-2 dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0437) by reversed-phase high-performance liquid chromatography after pre-column derivatization with d(+)-glucuronic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1990
1990
2004
2004

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…Stereospecific differences in in vitro glucuronidation has been described for E-lO-hydroxy- 1987) and for morphine (Coughtric et al 1989). Only slight differences between the in vitro glucuronidation of (+) and (-) N-0437 were found (Gerding et al 1989). Fig.…”
Section: Resultsmentioning
confidence: 98%
“…Stereospecific differences in in vitro glucuronidation has been described for E-lO-hydroxy- 1987) and for morphine (Coughtric et al 1989). Only slight differences between the in vitro glucuronidation of (+) and (-) N-0437 were found (Gerding et al 1989). Fig.…”
Section: Resultsmentioning
confidence: 98%
“…During the preparation of this study, Gerding et a1. 16 reported an indirect separation method for determination of the enantiomeric purity of (R)-and (S)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxy-0 1990 Wiley-Liss, Inc.…”
mentioning
confidence: 99%